256 related articles for article (PubMed ID: 9007853)
81. Autoradiographic comparison of [3H]-clonidine binding to non-adrenergic sites and alpha(2)-adrenergic receptors in human brain.
Piletz JE; Ordway GA; Zhu H; Duncan BJ; Halaris A
Neuropsychopharmacology; 2000 Dec; 23(6):697-708. PubMed ID: 11063925
[TBL] [Abstract][Full Text] [Related]
82. [3H]idazoxan binds to mitochondrial I2 imidazoline binding sites in isolated cells from rabbit kidney proximal tubule.
Gargalidis-Moudanos C; Parini A
Ann N Y Acad Sci; 1995 Jul; 763():172-3. PubMed ID: 7677328
[No Abstract] [Full Text] [Related]
83. Autoradiographical distribution of imidazoline binding sites in monoamine oxidase A deficient mice.
Anderson NJ; Seif I; Nutt DJ; Hudson AL; Robinson ES
J Neurochem; 2006 Mar; 96(6):1551-9. PubMed ID: 16476082
[TBL] [Abstract][Full Text] [Related]
84. Imidazoline-guanidinium receptive site in renal proximal tubule: asymmetric distribution, regulation by cations and interaction with an endogenous clonidine displacing substance.
Coupry I; Atlas D; Podevin RA; Uzielli I; Parini A
J Pharmacol Exp Ther; 1990 Jan; 252(1):293-9. PubMed ID: 2153803
[TBL] [Abstract][Full Text] [Related]
85. Binding of new cirazoline derivative to imidazoline receptors from human brain.
Dontenwill M; Ehrhardt JD; Senecheau P; Molines A; Greney H; Bousquet P
Neurochem Int; 1997 Jan; 30(1):9-16. PubMed ID: 9116592
[TBL] [Abstract][Full Text] [Related]
86. Characterization of alpha 2-adrenoceptor binding sites in rabbit ciliary body membranes.
Jin Y; Verstappen A; Yorio T
Invest Ophthalmol Vis Sci; 1994 Apr; 35(5):2500-8. PubMed ID: 8163339
[TBL] [Abstract][Full Text] [Related]
87. Adrenergic and imidazoline receptor-mediated responses to UK-14,304-18 (brimonidine) in rabbits and monkeys. A species difference.
Burke J; Kharlamb A; Shan T; Runde E; Padillo E; Manlapaz C; Wheeler L
Ann N Y Acad Sci; 1995 Jul; 763():78-95. PubMed ID: 7677389
[TBL] [Abstract][Full Text] [Related]
88. Identification and characterization of platelet α2-adrenoceptors and imidazoline receptors in rats, rabbits, cats, dogs, cattle, and horses.
Hikasa Y; Masuda K; Asakura Y; Yamashita Y; Sato C; Kamio M; Miura A; Taniguchi T; Minamizuru N
Eur J Pharmacol; 2013 Nov; 720(1-3):363-75. PubMed ID: 24120658
[TBL] [Abstract][Full Text] [Related]
89. Temporal changes in glial fibrillary acidic protein messenger RNA and [3H]PK11195 binding in relation to imidazoline-I2-receptor and alpha 2-adrenoceptor binding in the hippocampus following transient global forebrain ischaemia in the rat.
Conway EL; Gundlach AL; Craven JA
Neuroscience; 1998 Feb; 82(3):805-17. PubMed ID: 9483537
[TBL] [Abstract][Full Text] [Related]
90. Expression of non-adrenergic imidazoline sites in chromaffin cells and mitochondrial membranes of bovine adrenal medulla.
Regunathan S; Meeley MP; Reis DJ
Biochem Pharmacol; 1993 Apr; 45(8):1667-75. PubMed ID: 8387303
[TBL] [Abstract][Full Text] [Related]
91. Imidazolines stimulate release of insulin from RIN-5AH cells independently from imidazoline I1 and I2 receptors.
Olmos G; Kulkarni RN; Haque M; MacDermot J
Eur J Pharmacol; 1994 Sep; 262(1-2):41-8. PubMed ID: 7813577
[TBL] [Abstract][Full Text] [Related]
92. Synthesis and pharmacological evaluation of imidazoline sites I1 and I2 selective ligands.
Anastassiadou M; Danoun S; Crane L; Baziard-Mouysset G; Payard M; Caignard DH; Rettori MC; Renard P
Bioorg Med Chem; 2001 Mar; 9(3):585-92. PubMed ID: 11310592
[TBL] [Abstract][Full Text] [Related]
93. Selective antihypertensive action of moxonidine is mediated mainly by I1-imidazoline receptors in the rostral ventrolateral medulla.
Haxhiu MA; Dreshaj I; Schäfer SG; Ernsberger P
J Cardiovasc Pharmacol; 1994; 24 Suppl 1():S1-8. PubMed ID: 7533221
[TBL] [Abstract][Full Text] [Related]
94. Imidazoline binding sites in human placenta: evidence for heterogeneity and a search for physiological function.
Diamant S; Eldar-Geva T; Atlas D
Br J Pharmacol; 1992 May; 106(1):101-8. PubMed ID: 1324063
[TBL] [Abstract][Full Text] [Related]
95. Imidazoline receptors and agmatine in blood vessels: a novel system inhibiting vascular smooth muscle proliferation.
Regunathan S; Youngson C; Raasch W; Wang H; Reis DJ
J Pharmacol Exp Ther; 1996 Mar; 276(3):1272-82. PubMed ID: 8786560
[TBL] [Abstract][Full Text] [Related]
96. Binding of the imidazoline ligand 3H-2-benzofuranyl-2-imidazoline (BFI) to human brain and platelets. Potentiation by tranylcypromine and role of MAO isoforms.
Steinberg MI; Wiest SA; Pickard RT; Chen K; Shih JC
Ann N Y Acad Sci; 1999 Jun; 881():193-8. PubMed ID: 10415915
[No Abstract] [Full Text] [Related]
97. 5-Isothiocyanato-2-benzofuranyl-2-imidazoline (BU99006) an irreversible imidazoline(2) binding site ligand: in vitro and in vivo characterisation in rat brain.
Tyacke RJ; Robinson ES; Nutt DJ; Hudson AL
Neuropharmacology; 2002 Jul; 43(1):75-83. PubMed ID: 12213261
[TBL] [Abstract][Full Text] [Related]
98. Further characterization of the guinea pig cerebral cortex idazoxan receptor: solubilization, distinction from the imidazole site, and demonstration of cirazoline as an idazoxan receptor-selective drug.
Wikberg JE; Uhlén S
J Neurochem; 1990 Jul; 55(1):192-203. PubMed ID: 1972387
[TBL] [Abstract][Full Text] [Related]
99. Characterization of [(3)H]idazoxan binding sites on human platelets.
Ruiz J; Barinagarrementeria G; Martín-Gómez JI; Callado LF; Meana JJ
Platelets; 2002 Jun; 13(4):241-6. PubMed ID: 12189026
[TBL] [Abstract][Full Text] [Related]
100. Detomidine binding to guinea pig liver imidazoline receptors (I-receptors) shows marked positive cooperativity.
Rangel N; Uhlén S; Wikberg JE
Pharmacol Toxicol; 1993 Aug; 73(2):86-90. PubMed ID: 8248011
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
